Skip to main content
OpenTrials
Completed

NCT Number: NCT03718546

Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors

To compare donors to their non-donor counterparts and healthy controls as well as to generate trajectory classes based on longitudinal patterns of donor HRQoL and identify predictors of poor donor HRQoL.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

5 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Alabama at Birmingham, Birmingham, Alabama, United States

Loading trial locations.

About this study

There is limited data to show the effects that donation has on pediatric donors to their siblings. There is widespread agreement that it is critical to investigate the medical and psychosocial aspects of sibling pediatric HSC donation for multiple reasons including (a) the vulnerability of the pediatric population undergoing donation, (b) increasing use of pediatric HSC donation as a therapeutic option, (c) evidence that ~20% of pediatric HSC donors experience clinically important HRQoL deficits, and (d) the impact that improved understanding of factors predicting poor HRQoL will have on our ability to develop guidelines and/or interventions for assisting at-risk donors/families. The proposed study will help to compare donors to their non-donor counterparts and healthy controls as well as to generate trajectory classes based on longitudinal patterns of donor HRQoL and identify predictors of poor donor HRQoL.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants must fall into one of the following categories:
  • Donor between the age of 5 and 17 who is donating to a sibling
  • Parent/caregiver of study participating donor
  • Recipient sibling aged 5 to 17 of study participating donor
  • Any of the donor's non-donor/non-recipient siblings between 5 and 17
  • Any child between 5 and 17 with a brother or sister (also between 5 and 17) receiving a transplant from an unrelated source
  • Be willing and able to provide signed informed consent:
  • Adults must give consent for their children's and, if applicable, their own participation
  • Assent will be obtained in accordance with guidelines at the participant's transplant institution
  • Be willing and able to respond to psychological assessment questions
  • Must be the donor's first donation
  • Recipient must consent to the CIBMTR research database

Exclusion criteria

  • For families with pediatric donors aged 5 to 17, at minimum, the donor child and/or one parent must consent/assent to participation. If that minimum is not met, the family will be excluded
  • Donor or non-donor siblings who do not live in the same household as the recipient at lease half of the time
  • Unable to consent/assent or complete a phone interview in English
  • Parents may consent/assent in Spanish
  • No access to a telephone

Treatment and study plan

Primary outcomes

  1. HRQoL (Health Related Quality of Life)

    Time frame: 1 year

    To longitudinally and quantitatively describe the HRQoL of a diverse nation-wide cohort of sibling pediatric Hematopoietic Stem Cell (HSC) donors (Peripheral Blood Stem Cell or Bone Marrow) and to compare their HRQoL to that of (1) healthy non-donor sibling from the same family, (2) siblings of children with similar diseases who receive alternate treatments (e.g., unrelated cord blood transplants), and (3) healthy age, gender, and race/ethnicity-matched controls.

Secondary outcomes

  1. 1 year post-donation

    Time frame: 1 year

    To identify and examine donor HRQoL trajectories from pre- through 1 year post-donation.

  2. Donor characteristics

    Time frame: 1 year

    To determine which donor characteristics (e.g., demographic, psychosocial, and donation-related), recipient characteristics (e.g., recipient disease, transplant complications and outcomes), family characteristics (e.g., composition, cohesiveness, stress), and transplant center characteristics (e.g., presence of a donor advocate) most strongly predict membership in trajectory classes with poor HRQoL among donors.

Sponsors and collaborators

Lead sponsor

Center for International Blood and Marrow Transplant Research

Network

Collaborators

  • University of Pittsburgh

Registry information

Important dates

Study start
2019
Primary completion
2024
Study completion
2024
First posted
Oct 24, 2018
Registry last updated
Mar 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.